CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 双富马酸依美斯汀Emedastine Difumarate
Emedastine Difumarate

双富马酸依美斯汀 杂质对照品Emedastine Difumarate Impurities

EP29 个杂质条目29 impurity entries

本页汇总 双富马酸依美斯汀 的 29 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 29 impurity reference standards of Emedastine Difumarate with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 双富马酸依美斯汀(Emedastine Difumarate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsHigh-performance liquid chromatography-electrospray ionization-mass spectrometric determination of emedastine difumarate in human plasma and its pharmacokinetics
    Journal of chromatographic science · 2007 · Tian Y et al.  ·  PMID 17462131  ·  DOI
  2. 分析方法Analytical Methods[Selective and sensitive determination of an antiallergic agent, emedastine difumarate (KG-2413), in human plasma by the radioreceptor assay combined with a high-performance liquid chromatography]
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan · 1989 · Hamada T et al.  ·  PMID 2576060  ·  DOI

双富马酸依美斯汀 —— 原料药与杂质对照品Emedastine Difumarate — drug substance & impurities

共 29 个条目(含原料药本体)29 items incl. the drug substance
Emedastine Difumarate structure
EP原料药 APIAPI
双富马酸依美斯汀Emedastine Difumarate
Emedastine Difumarate
CAS No.87233-62-3
Chemical FormulaC17H26N4O·2(C4H4O4)
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 1(Emedastine Difumarate EP Impurity A) structure
EPA
双富马酸依美斯汀杂质1(双富马酸依美斯汀EP杂质A)Emedastine Difumarate Impurity 1(Emedastine Difumarate EP Impurity A)
Emedastine Difumarate Impurity 1(Emedastine Difumarate EP Impurity A)
CAS No.101953-61-1
Chemical FormulaC11H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 2(Emedastine Difumarate EP Impurity B) structure
EPB
双富马酸依美斯汀杂质2(双富马酸依美斯汀EP杂质B)Emedastine Difumarate Impurity 2(Emedastine Difumarate EP Impurity B)
Emedastine Difumarate Impurity 2(Emedastine Difumarate EP Impurity B)
CAS No.87233-54-3
Chemical FormulaC11H13ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 4 Monomer (Emedastine Difumarate EP Impurity C) structure
EPC
双富马酸依美斯汀杂质4 单体 (双富马酸依美斯汀EP杂质C)Emedastine Difumarate Impurity 4 Monomer (Emedastine Difumarate EP Impurity C)
Emedastine Difumarate Impurity 4 Monomer (Emedastine Difumarate EP Impurity C)
CAS No.122423-32-9
Chemical FormulaC15H22N4O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 5 Monomer (Emedastine Difumarate EP Impurity D) structure
EPD
双富马酸依美斯汀杂质5 单体 (双富马酸依美斯汀EP杂质D)Emedastine Difumarate Impurity 5 Monomer (Emedastine Difumarate EP Impurity D)
Emedastine Difumarate Impurity 5 Monomer (Emedastine Difumarate EP Impurity D)
CAS No.130263-14-8
Chemical FormulaC15H20N4
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 6 Monomer (Emedastine Difumarate EP Impurity E) structure
EPE
双富马酸依美斯汀杂质6 单体 (双富马酸依美斯汀EP杂质E)Emedastine Difumarate Impurity 6 Monomer (Emedastine Difumarate EP Impurity E)
Emedastine Difumarate Impurity 6 Monomer (Emedastine Difumarate EP Impurity E)
CAS No.101954-20-5
Chemical FormulaC16H24N4O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine structure
—
依美斯汀Emedastine
Emedastine
CAS No.87233-61-2
Chemical FormulaC17H26N4O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 7 structure
7
双富马酸依美斯汀杂质7Emedastine Difumarate Impurity 7
Emedastine Difumarate Impurity 7
CAS No.122484-65-5
Chemical FormulaC17H26N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 8 structure
8
双富马酸依美斯汀杂质8Emedastine Difumarate Impurity 8
Emedastine Difumarate Impurity 8
CAS No.59039-76-8
Chemical FormulaC13H20N2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 10 structure
10
双富马酸依美斯汀杂质10Emedastine Difumarate Impurity 10
Emedastine Difumarate Impurity 10
CAS No.1620097-06-4
Chemical FormulaC13H20N2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 13 structure
13
双富马酸依美斯汀杂质13Emedastine Difumarate Impurity 13
Emedastine Difumarate Impurity 13
CAS No.29053-62-1
Chemical FormulaC6H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 15 structure
15
双富马酸依美斯汀杂质15Emedastine Difumarate Impurity 15
Emedastine Difumarate Impurity 15
CAS No.24370-25-0
Chemical FormulaC8H8N4O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 17 structure
17
双富马酸依美斯汀杂质17Emedastine Difumarate Impurity 17
Emedastine Difumarate Impurity 17
CAS No.101954-22-7
Chemical FormulaC18H28N4O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 20 structure
20
双富马酸依美斯汀杂质20Emedastine Difumarate Impurity 20
Emedastine Difumarate Impurity 20
CAS No.845937-00-0
Chemical FormulaC6H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 25 structure
25
双富马酸依美斯汀杂质25Emedastine Difumarate Impurity 25
Emedastine Difumarate Impurity 25
CAS No.1027187-58-1
Chemical FormulaC10H11ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 26 structure
26
双富马酸依美斯汀杂质26Emedastine Difumarate Impurity 26
Emedastine Difumarate Impurity 26
CAS No.40019-65-6
Chemical FormulaC9H9ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 29 structure
29
双富马酸依美斯汀杂质29Emedastine Difumarate Impurity 29
Emedastine Difumarate Impurity 29
CAS No.2326122-68-1
Chemical FormulaC10H22N2O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 31 structure
31
双富马酸依美斯汀杂质31Emedastine Difumarate Impurity 31
Emedastine Difumarate Impurity 31
CAS No.441787-37-7
Chemical FormulaC27H36N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 33 structure
33
双富马酸依美斯汀杂质33Emedastine Difumarate Impurity 33
Emedastine Difumarate Impurity 33
CAS No.4410-12-2
Chemical FormulaC12H18N2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 34 structure
34
双富马酸依美斯汀杂质34Emedastine Difumarate Impurity 34
Emedastine Difumarate Impurity 34
CAS No.199671-52-8
Chemical FormulaC13H18N2O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 35 structure
35
双富马酸依美斯汀杂质35Emedastine Difumarate Impurity 35
Emedastine Difumarate Impurity 35
CAS No.150651-61-9
Chemical FormulaC13H20N2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 37 structure
37
双富马酸依美斯汀杂质37Emedastine Difumarate Impurity 37
Emedastine Difumarate Impurity 37
CAS No.13201-86-0
Chemical FormulaC13H10N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Impurity C38 structure
C38
依美斯汀杂质C38Emedastine Impurity C38
Emedastine Impurity C38
CAS No.101953-62-2
Chemical FormulaC13H18N4
Purity>95%现货In stock
10mg25mg50mg100mg
Emedastine Difumarate Impurity 44 structure
44
双富马酸依美斯汀杂质44Emedastine Difumarate Impurity 44
Emedastine Difumarate Impurity 44
CAS No.65504-34-9
Chemical FormulaC6H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 45 structure
45
双富马酸依美斯汀杂质45Emedastine Difumarate Impurity 45
Emedastine Difumarate Impurity 45
CAS No.87233-57-6
Chemical FormulaC18H24N4O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 47 structure
47
双富马酸依美斯汀杂质47Emedastine Difumarate Impurity 47
Emedastine Difumarate Impurity 47
CAS No.1474068-93-3
Chemical FormulaC15H22N4O
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 52 structure
52
双富马酸依美斯汀杂质52Emedastine Difumarate Impurity 52
Emedastine Difumarate Impurity 52
CAS No.4318-37-0
Chemical FormulaC6H14N2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 55 structure
55
双富马酸依美斯汀杂质55Emedastine Difumarate Impurity 55
Emedastine Difumarate Impurity 55
CAS No.55754-08-0
Chemical FormulaC9H8Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Emedastine Difumarate Impurity 56 structure
56
双富马酸依美斯汀杂质56Emedastine Difumarate Impurity 56
Emedastine Difumarate Impurity 56
CAS No.1253736-91-2
Chemical FormulaC10H13N3O
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

双富马酸依美斯汀 —— 研究文献与合成路线Emedastine Difumarate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 双富马酸依美斯汀 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Emedastine Difumarate. Titles link to the original records; copyright remains with the authors and publishers.

合成路线文献Synthetic-route papers

  1. Emedastine difumarate inhibits histamine-induced collagen synthesis in dermal fibroblasts
    Murota H, Bae S, Hamasaki Y, et al. · Journal of investigational allergology & clinical immunology · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

双富马酸依美斯汀 杂质谱研究要点Emedastine Difumarate — impurity profiling notes

下面这些是拿到 双富马酸依美斯汀 的 29 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 29 impurity entries for Emedastine Difumarate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances